HealthTree Radio for AML: James Blachly, MD, Ohio State University
Progress in understanding AML and developing therapies that treat this blood cancer is occurring at an astounding pace. In this radio show, Dr. James Blachly, an AML expert from the James Comprehensiv...
25 Okt 20211h 5min
Harnessing the Immune System in Relapsed AML: Dr. Reagan, Rhode Island Hospital
The use of the immune system to treat patients with AML is being heavily pursued as a strategy to more effectively fight AML and give patients with relapsed or refractory disease a better chance at ac...
30 Sep 202159min
HealthTree for AML Radio: Gabriel Mannis, MD, Stanford Cancer Institute
Dr. Gabriel Mannis of the Stanford Cancer Institute is studying what could become the first all oral therapy for newly diagnosed AML. The combination of venetoclax and decitabine with cedazuridine (AS...
13 Sep 202159min
